Live Breaking News & Updates on India covid working group

Stay informed with the latest breaking news from India covid working group on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in India covid working group and stay connected to the pulse of your community

WHO Estimate Of India Deaths "Preposterous, Untenable": Covid Panel Chief

WHO also said they chose the mathematical model as many countries "still lack capacity for reliable mortality surveillance and therefore do not collect and generate the data needed to calculate excess mortality".

India , Kerala , Supreme-court , Covid-working-group , India-covid-working-group , World-health-organisation , Civil-registration-system , India-covid-deaths , Nk-arora , Who-report , Who-news

Coronavirus, India Covid Numbers, Prabhat Jha To NDTV: India 2020 Data "Corroborates"...: Expert Explains WHO Covid Deaths Report

In the massive controversy over the World Health Organisation (WHO) report claiming 4.7 million "excess" Covid deaths in India and the government's sharp rebuttals, a member of the WHO's Technical Advisory Group (TAG) says the data is corroborated.

India , Prabhat-jha , Covid-working-group , Technical-advisory-group , India-covid-working-group , World-health-organisation , Advisory-group , Civil-registration , Civil-registration-system-data , Civil-registration-system , India-covid-death-numbers , India-covid-deaths

Should India reduce gap between Covishield doses based on UK vaccine efficacy data for new variant?


Members of India’s Covid Working Group don’t think so.
2 hours ago
A health worker prepares to administer a dose of the Covishield, AstraZeneca-Oxford's Covid-19 coronavirus vaccine, at a vaccination centre in Mumbai on April 1.
|
Punit Paranjpe / AFP
On May 13, when the Indian government increased the duration between two doses of the Covishield vaccine to 12 weeks-16 weeks from eight weeks-six weeks, it cited “real life evidences, particularly from UK”.
The decision, according to members of India’s Covid Working Group that recommended it, was driven by studies that suggested that the first dose of the vaccine, developed by Oxford University and the British-Swedish company AstraZeneca, provided substantial protection.

Sweden , India , United-kingdom , Puducherry , Pondicherry , Scotland , British , Swedish , Jayaprakash-muliyil , Gagandeep-kang , Jacob-john , Rakesh-agarwal